Quoin Pharmaceuticals, Ltd. - 8-K Filing
Quoin Pharmaceuticals raised $50M in private placement for QRX003 development; reported positive interim Phase 2/3 results. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 7.01 Regulation FD Disclosure, 8.01 Other Events On August 28, 2026, the Company announced positive interim results from CL-QRX003-004, its ongoing Phase 2/3 study of QRX003 4%)
Tickers: $QNRX